Pneumonia Severity Index (PSI / PORT score) (also searched as Pneumonia Patient Outcomes Research Team score, PSI score, PORT score, ICD-10: J18.9) is a rigorously validated 20-variable prognostic prediction rule that objectively estimates short-term morbidity and 30-day mortality in adult patients presenting with community-acquired pneumonia (CAP)1,2. Developed to assist clinicians in making safe, evidence-based site-of-care decisions, the PSI separates patients into five distinct risk classes (I through V) based on demographic characteristics, comorbid medical conditions, physical examination findings, laboratory values, and radiographic abnormalities2. By quantifying individual patient risk, the index safely increases the proportion of low-risk individuals treated effectively in the outpatient setting while ensuring high-risk patients receive immediate inpatient or intensive care unit admission2,3.

Etiology & Risk Factors

  • Age-Related Vulnerability: Advanced age serves as a primary driver of score accumulation due to physiological immunosenescence and decreased pulmonary reserve1,2.
  • Comorbid Conditions: Pre-existing neoplastic disease, liver disease (cirrhosis or chronic hepatitis), congestive heart failure, cerebrovascular disease, and renal disease significantly elevate baseline point totals and mortality risk1,2.
  • Anatomical & Physiological Derangements: Altered mental status, core body temperature abnormalities (<35°C or >40°C), tachypnea (respiratory rate ≥30 breaths/min), and systolic hypotension (<90 mmHg) reflect severe systemic response and physiological decompensation.
  • Laboratory Alterations: Arterial pH <7.35, blood urea nitrogen (BUN) >30 mg/dL (>11 mmol/L), serum sodium <130 mEq/L, glucose >250 mg/dL, hematocrit <30%, and partial pressure of arterial oxygen (PaO2) <60 mmHg or oxygen saturation <90% indicate critical metabolic and gas-exchange impairment.
  • Radiographic Findings: The presence of pleural effusions on chest radiography denotes advanced disease severity and complicated infection2.

Pathophysiology

The pathophysiological foundation underlying the utility of the Pneumonia Severity Index centers on the host response to lower respiratory tract infection and the compounding burden of underlying systemic illness. When bacterial, viral, or atypical pathogens invade the distal alveolar spaces, localized inflammation triggers the exudation of fluid, erythrocytes, and leukocytes into the alveoli, resulting in ventilation-perfusion mismatch and impaired gas exchange. In patients with robust physiologic reserves, localized pulmonary consolidation is readily contained; however, in elderly individuals or those with comorbid cardiovascular, hepatic, or renal dysfunction, the localized pulmonary insult precipitates systemic inflammatory response syndrome (SIRS). This systemic cascade leads to peripheral vasodilation, relative hypovolemia, myocardial strain, and impaired tissue perfusion. The variables incorporated into the PSI capture this multi-organ vulnerability—ranging from renal hypoperfusion (reflected by elevated BUN) and electrolyte shifts (hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion or volume depletion) to gas exchange failure (hypoxemia and acidemia). Consequently, the composite score serves as a reliable surrogate for total physiological reserve and the organism's capacity to withstand the metabolic demands of severe infection.

Pneumonia Severity Index (PSI / PORT score) — Pathophysiological Cascade & Clinical Flowchart 1 Initial Patient Presentation Presentation of community-acquired pulmonary infection with baseline comorbid states 2 Variable Extraction & Scoring Aggregation of 20 demographic, clinical, laboratory, and radiographic risk variables 3 Risk Stratification Categorization into five distinct prognostic risk classes (Classes I through V) 4 Site-of-Care Determination Guiding safe outpatient management vs. hospital or intensive care admission 5 Therapeutic Intervention & Outcome Optimization Targeted antimicrobial therapy and supportive care to reduce 30-day mortality

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with an acute onset of productive cough, purulent or rust-colored sputum, fever, chills, and pleuritic chest pain. Systemic symptoms such as generalized malaise, myalgias, fatigue, and varying degrees of dyspnea are universally present. In elderly cohorts, atypical presentations including acute confusion, lethargy, falls, or acute functional decline often overshadow classic respiratory complaints.
  • Physical Examination & Named Clinical Signs: Examination reveals tachypnea, tachycardia, and a temperature of either fever or hypothermia. Chest examination demonstrates focal signs of consolidation including dullness to percussion, increased tactile fremitus, bronchial breath sounds, and inspiratory crackles (rales). Egophony ("E to A changes") is frequently elicited over areas of lobar consolidation. Signs of respiratory distress, such as the use of accessory muscles of respiration and intercostal retractions, are prominent in higher-risk classes.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationChest radiography (posteroanterior and lateral views) demonstrating focal lobar consolidation, patchy interstitial infiltrates, or associated pleural effusions.
Laboratory PanelComplete blood count showing leukocytosis with a left shift (>12,000/μL with >10% band forms) or leukopenia (<4,000/μL); comprehensive metabolic panel revealing elevated blood urea nitrogen, serum creatinine, and hyponatremia; arterial blood gas demonstrating hypoxemia and potential metabolic or respiratory acid-base disturbances.
Imaging / Radiology (X-ray, US, CT, MRI)Thoracic ultrasound or computed tomography (CT) reserved for complicated cases to identify occult pulmonary abscesses, empyema, or significant parapneumonic effusions.
ECG / Histopathology / Procedural12-lead electrocardiogram to evaluate for acute myocardial strain or ischemia secondary to sepsis and hypoxia; sputum Gram stain and culture for pathogen identification in inpatient cohorts.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Demographic CharacteristicsAge: Men = Age in years; Women = Age in years minus 10 points. Nursing home resident = +10 points.
Comorbid IllnessesNeoplastic disease = +30 points; Liver disease = +20 points; Congestive heart failure = +10 points; Cerebrovascular disease = +10 points; Renal disease = +10 points.
Physical Examination FindingsAltered mental status = +20 points; Pulse ≥125 beats/min = +20 points; Respiratory rate ≥30 breaths/min = +20 points; Systolic blood pressure <90 mmHg = +20 points; Temperature <35°C or ≥40°C = +15 points.
Laboratory & Radiographic FindingsArterial pH <7.35 = +30 points; BUN >30 mg/dL (>11 mmol/L) = +20 points; Sodium <130 mEq/L = +20 points; Glucose >250 mg/dL = +10 points; Hematocrit <30% = +10 points; PaO2 <60```html

Pneumonia Severity Index (PSI / PORT score) (also searched with possessive/alternate eponym spelling where applicable, ICD-10: J18.9) is an extensively validated, objective prediction rule designed to estimate 30-day mortality and guide site-of-care decisions for adult patients presenting with community-acquired pneumonia (CAP) 1,2. Developed by the Pneumonia Outcomes Research Team (PORT), the index utilizes twenty routinely available demographic, clinical, laboratory, and radiographic variables to stratify patients into five distinct risk classes (Classes I–V) 2. By quantifying host vulnerability and the physiological impact of acute pulmonary infection, the PSI serves as a reference standard in emergency medicine and pulmonology, safely identifying low-risk individuals who can be effectively and economically treated in the outpatient setting while ensuring high-risk patients are promptly admitted for inpatient or intensive care unit monitoring 2,3.

Etiology & Risk Factors

  • Primary Pathogens in CAP: Streptococcus pneumoniae remains the leading bacterial cause, followed by atypical organisms such as Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella species, and respiratory viruses (e.g., Influenza, SARS-CoV-2, Respiratory Syncytial Virus)1,2.
  • Demographic Risk Factors: Advanced age is heavily weighted in the PSI scoring system, reflecting age-related immunosenescence and decreased physiological reserve2. Male sex and nursing home residency independently increase baseline prognostic risk.
  • Comorbid Conditions: Underlying neoplastic disease, chronic liver disease (cirrhosis), congestive heart failure, cerebrovascular disease, and chronic renal disease add significant points to the index due to their profound impact on systemic reserve and mortality1,2.
  • Anatomical and Physiological Derangements: Altered mental status, core temperature abnormalities (hypothermia or high fever), tachycardia, tachypnea, and systolic hypotension reflect severe systemic inflammatory response and organ hypoperfusion3.

Pathophysiology

Community-acquired pneumonia begins when respiratory pathogens evade host mechanical upper airway defenses and reach the terminal bronchioles and alveoli, triggering a localized alveolar inflammatory cascade characterized by the release of pro-inflammatory cytokines (such as tumor necrosis factor-alpha and interleukin-1) and the influx of neutrophils and exudative fluid into the alveolar spaces. This inflammatory exudate impairs gas exchange across the alveolar-capillary membrane, leading to ventilation-perfusion mismatch, intrapulmonary shunting, and hypoxemia. The systemic spillover of inflammatory mediators induces systemic vasodilation, increased capillary permeability, and myocardial suppression, which clinically manifest as tachypnea, tachycardia, hypotension, and elevated serum lactate or blood urea nitrogen. The PSI mathematically captures this multi-system physiological compromise by integrating baseline frailty, comorbid organ dysfunction, and acute vital sign aberrations into a unified prognostic score1,2.

Pneumonia Severity Index (PSI / PORT score) — Pathophysiological Cascade & Clinical Flowchart 1 Initial Patient Presentation Presentation of community-acquired pulmonary infection with baseline comorbid states 2 Variable Extraction & Scoring Aggregation of 20 demographic, clinical, laboratory, and radiographic risk variables 3 Risk Stratification Categorization into five distinct prognostic risk classes (Classes I through V) 4 Site-of-Care Determination Guiding safe outpatient management vs. hospital or intensive care admission 5 Therapeutic Intervention & Outcome Optimization Targeted antimicrobial therapy and supportive care to reduce 30-day mortality

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with an acute or subacute onset of cough (productive of rust-colored, purulent, or blood-tinged sputum), dyspnea, pleuritic chest pain, and systemic symptoms including high fever, chills, rigors, malaise, myalgias, and fatigue. Elderly patients may present atypically with acute confusion, lethargy, falls, or worsening of baseline chronic conditions without prominent respiratory complaints.
  • Physical Examination & Named Clinical Signs: Examination reveals tachypnea, use of accessory muscles of respiration, and tachycardia. Auscultation demonstrates bronchial breath sounds, localized crackles (rales), egophony ("E to A" changes), whispered pectoriloquy, and dullness to percussion over areas of consolidation. Pleuritic friction rubs may be appreciated if adjacent pleuritis is present.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationChest radiography (posteroanterior and lateral views) demonstrating lobar or patchy airspace consolidation, interstitial infiltrates, or pleural effusion, evaluated alongside the 20-variable PSI calculation.
Laboratory PanelComplete blood count showing leukocytosis with a left shift (bandemia) or leukopenia in severe cases; arterial blood gas analysis revealing hypoxemia and potential respiratory alkalosis progressing to acidosis; elevated blood urea nitrogen (BUN) and creatinine reflecting dehydration or acute kidney injury; hyponatremia.
Imaging / Radiology (X-ray, US, CT, MRI)Chest X-ray confirms focal or multi-lobar consolidation. Chest CT may be utilized in complex cases or when complications such as empyema, lung abscess, or pulmonary infarction are suspected. Lung ultrasound can rapidly identify subpleural consolidations and dynamic air bronchograms.
ECG / Histopathology / Procedural12-lead ECG to evaluate for acute myocardial ischemia or strain precipitated by hypoxemia and tachycardia. Sputum Gram stain and culture, blood cultures, and urinary antigen tests for Streptococcus pneumoniae and Legionella pneumophila in hospitalized or severe cases.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Demographics & Nursing Home StatusAge: Males add age in years; Females add age in years minus 10. Nursing home resident: +10 points.
Comorbid IllnessesNeoplastic disease (+30), Liver disease (+20), Congestive heart failure (+10), Cerebrovascular disease (+10), Renal disease (+10).
Physical Examination FindingsAltered mental status (+20), Respiratory rate ≥ 30 breaths/min (+20), Systolic blood pressure < 90 mmHg (+20), Temperature < 35°C or ≥ 40°C (+15), Pulse ≥ 125 beats/min (+10).
Laboratory & Radiographic FindingsArterial pH < 7.35 (+30), BUN > 30 mg/dL (+20), Sodium < 130 mEq/L (+20), Glucose > 250 mg/dL (+10), Hematocrit < 30% (+10), Partial pressure of oxygen < 60 mmHg (+10), Pleural effusion (+10).
Risk Classes & Mortality StratificationClass I (Age < 50, no comorbidities/abnormal vitals/labs); Class II (Score ≤ 70); Class III (Score 71–90); Class IV (Score 91–130, inpatient admission recommended); Class V (Score > 130, ICU or high-level inpatient care required).

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute Decompensated Heart FailurePresents with dyspnea, orthopnea, and crackles, but chest radiography demonstrates cardiomegaly, cephalization of pulmonary vessels, Kerley B lines, and pleural effusions without focal lobar consolidation. BNP or NT-proBNP is markedly elevated.
Pulmonary EmbolismCharacterized by acute pleuritic chest pain, dyspnea, and tachycardia in the presence of risk factors. Chest radiograph is frequently normal or shows non-specific atelectasis. CT pulmonary angiography confirms filling defects in the pulmonary arterial tree.
AtelectasisMarked by volume loss with tracheal deviation toward the affected side and elevated hemidiaphragm on chest radiography, distinguishing it from the volume-neutral or expansive consolidation of pneumonia.
Non-Infectious Pneumonitis (e.g., Hypersensitivity or Aspiration)History of toxic exposure or chemical/gastric content aspiration. Fever and leukocytosis may be absent initially, and clinical response to broad-spectrum antimicrobials alone is poor without addressing the underlying inflammatory or mechanical trigger.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Assess airway, breathing, and circulation. Administer supplemental oxygen to maintain target oxygen saturations of 92–98% (88–92% in chronic obstructive pulmonary disease at risk of hypercapnia). Provide IV fluid resuscitation cautiously for hypotension or signs of sepsis-induced tissue hypoperfusion.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Outpatient (No comorbidities): Amoxicillin 1 g orally three times daily, or doxycycline 100 mg orally twice daily, or a macrolide (azithromycin 500 mg day 1, then 250 mg daily) if local macrolide resistance is < 25%.
    • Outpatient (With comorbidities): Combination therapy with amoxicillin/clavulanate 875/125 mg orally twice daily (or cefpodoxime 200 mg twice daily) PLUS azithromycin 500 mg day 1 then 250 mg daily (or doxycycline 100 mg twice daily), OR respiratory fluoroquinolone monotherapy (levofloxacin 750 mg orally daily or moxifloxacin 400 mg orally daily).
    • Inpatient (Non-ICU): Ceftriaxone 1 to 2 g IV every 24 hours PLUS azithromycin 500 mg IV/oral daily, OR respiratory fluoroquinolone monotherapy (levofloxacin 750 mg IV daily).
    • Inpatient (ICU): Ceftriaxone 2 g IV every 24 hours PLUS levofloxacin 750 mg IV daily or azithromycin 500 mg IV daily, with consideration of vancomycin (15–20 mg/kg IV every 8–12 hours) or linezolid (600 mg IV every 12 hours) if methicillin-resistant Staphylococcus aureus risk is present, and anti-pseudomonal coverage (e.g., cefepime 2 g IV every 8 hours) if risk factors for Pseudomonas aeruginosa exist.
  • Surgical / Interventional Indications: Diagnostic thoracentesis and subsequent chest tube placement or video-assisted thoracoscopic surgery (VATS) for complicated parapneumonic effusions or empyema. Bronchoscopy with bronchoalveolar lavage for non-responding patients or immunocompromised hosts to obtain definitive microbiological diagnosis.

Complications & Prognosis

  • Key acute complications include respiratory failure requiring mechanical ventilation, septic shock, acute respiratory distress syndrome (ARDS), parapneumonic effusion, empyema, lung abscess, and metastatic infection (e.g., meningitis, endocarditis)1,3.
  • Long-term risks include prolonged post-pneumonia fatigue, functional decline in elderly cohorts, and increased cardiovascular events following systemic inflammatory insults.
  • Prognosis is directly correlated with the calculated PSI risk class; mortality ranges from less than 0.5% in Class I up to greater than 27% in Class V, reinforcing the clinical necessity of accurate risk stratification to dictate appropriate site-of-care admission2,3.

🎓 Board Exam Pearls & Clinical Pitfalls

  • Exam Pearl 1: The PSI/PORT score incorporates age as a continuous variable where every year of age equals one point for men, whereas women have a baseline age adjustment subtracting 10 points.
  • Clinical Pitfall 2: Relying solely on the PSI score without clinical gestalt can lead to discharging a patient with severe social instability or profound hypoxemia despite a low numerical risk class.
  • Board Pearl 3: Unlike CURB-65, which is simpler to calculate at the bedside, the PSI includes extensive laboratory and radiographic parameters, making it more sensitive for identifying truly low-risk patients who can be safely managed out of the hospital.

⚡ At-a-Glance Clinical Summary Card

ICD-10: J18.9ICD-11: CA40.Z
⚡ High-Yield Clinical Summary
The Pneumonia Severity Index (PSI / PORT score) is a validated 20-variable prognostic prediction rule that objectively stratifies adult patients with community-acquired pneumonia into five risk classes to guide safe outpatient versus inpatient site-of-care decisions. Gold-standard evaluation involves chest radiography combined with complete blood counts, arterial blood gas analysis, and renal function panels, while management ranges from supportive outpatient oral antimicrobial therapy to intensive care unit admission depending on risk class.
🩺 Specialty
Respiratory
🎯 Classic Triad / Hallmark Presentation
Cough, fever, and dyspnea accompanied by systemic fatigue and risk-stratifying comorbid variables
🔬 Gold-Standard Diagnostic Test
Chest radiography demonstrating lobar or interstitial pulmonary infiltrates coupled with multi-variable prognostic risk scoring
💊 First-Line Treatment Protocol
Outpatient oral empiric beta-lactam combined with a macrolide or respiratory fluoroquinolone for low-risk classes; inpatient broad-spectrum parenteral therapy for high-risk classes
Respiratory Classifications & Scoring Systems mID 10145 · v1
✍️ Authored & revised by Pulathi Senaratna (Senior Editor)
Cite as: Senaratna P, Pneumonia Severity Index (PSI / PORT score). Reference article, Medipaedia.org (Accessed on 15 Nov 2026) https://medipaedia.org/articles/10145